Comparative Assessment of Clinical Outcomes Between Abiraterone Acetate and Enzalutamide in Patients With Docetaxel-Naive Metastatic Castration-Resistant Prostate Cancer: Experience in Real-World Clinical Practice in Japan

Both AA and Enz were effective and tolerable for patients with docetaxel-naive mCRPC in the routine clinical setting.